Transatlantic divide: First-line therapy for acute colitis

Practical Gastroenterology

Volumn 29, Issue 3, 2005, Pages 66-70

  Travis, Simon ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN; MESALAZINE; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE;

ACNE; ATLANTIC OCEAN; BONE NECROSIS; CLINICAL TRIAL; COLITIS; COLON RESECTION; DISEASE ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; EDEMA; EUROPE; EVIDENCE BASED MEDICINE; FLUID RETENTION; HUMAN; META ANALYSIS; MOON FACE; PRACTICE GUIDELINE; REVIEW; SIDE EFFECT; STEROID THERAPY; SYSTEMATIC REVIEW; UNITED STATES;

EID: 19444376433     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Kornbluth A, Sachar DS. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol, 2004;99:1371-1385.
2. Carter MJ, Lobo AJ, Travis SPL. Guidelines for the management of inflammatory bowel disease in adults. Gut, 2004;53 Suppl V:v1-16.
3. Hardy TL, Bulmer E. Ulcerative colitis: survey of 95 cases. Br Med J, 1933;ii:812-815.
4. Rice-Oxley JM, Truelove SC. Ulcerative colitis: course and prognosis. Lancet, 1950;i:663-666.
5. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: a final report on a therapeutic trial. Br Med J. 1955;2:1041-1048.
6. Travis SPL, Farrant JM, Ricketts C. et al. Predicting outcome in severe ulcerative colitis. Gut. 1996;38:905-910.
7. Truelove SC, Watkinson G, Draper G. Comparison of corticosteroid and SASP therapy in ulcerative colitis. Br Med J, 1962;2: 1708-1711.
8. Lennard-Jones JE, Longmore AJ, Newell AC, Wilson CWE, Avery Jones F. An assessment of prednisone, Salazopyrin and topical hydrocortisone hemisuccinate used as outpatient treatment for ulcerative colitis. Gut, 1960;1:217-222.
9. Baron JH, Connell AM, Kanaghinis TG, et al. Outpatient treatment of ulcerative colitis: comparison between three doses of oral prednisone. Br Med J. 1962;2:441-443.
10. Loftus EV, Kane SV, Bjorkman D. Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis. Aliment Pharmacol Ther, 2004;19:179-189.
11. Freeman HJ. Osteomyelitis and osteonecrosis in inflammatory bowel disease. Can J Gastroenterol, 1997;11:601-606.
12. Ransford RAJ, Langman MJS. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut, 2002;51:536-539.
13. Stenner JMC, White P, Gould SR, Lim AG. Audit of the management of severe ulcerative colitis in a DGH. Gut, 2001;48: A87.
14. Sandborn WJ, Hanauer SB, Katz S, et al. Efficacy and safety of Asacol 4.8 g/day (800 mg tablet) compared to 2.4 g/day (400 mg tablet) in treating moderately active ulcerative colitis. Am J Gastroenterol, 2004; S251.
15. Bebb JR, Scott BB. Systematic review: how effective are the usual treatments for ulcerative colitis? Aliment Pharmacol Ther, 2004;20:143-149.
16. Hanauer S, Schwartz J, Robinson M. et al. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group. Am J Gastroenterol, 1993;88:1188-1197.
17. Marteau PR, Probert C, Lindgren S, et al. Comparison of the efficacy and tolerability of oral 4 g Pentasa (mesalazine) for 8 weeks combined during the initial 4 weeks with either Pentasa Ig/100 ml enema or placebo enema in extensive mild/moderate active colitis: a randomised, parallel, double-blind trial. Gut, 2004;53 Suppl VI:A226.
18. Safdi M, DeMicco M, Sninsky C, et al. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Am J Gastroenterol, 1997;92:1867-1871.
19. Sutherland L, MacDonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev, 2003;3:CD000543.
20. Sutherland L, Roth D, Beck P, May G, Makiyama K. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev, 2002;4:CD000544.
21. Faubion WA Jr. Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology, 2001;121:255-60.